HighTower Advisors
GDRX icon

HighTower Advisors’s GoodRx Holdings GDRX Stock Holding History

HighTower Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-153
Closed -$24K – 3248
2021
Q1 		$24K Buy
+153
New +$6.88K ﹤0.01% 2887

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

HighTower Advisors's GDRX Position: Q2 2026 in Review

HighTower Advisors reduced its GoodRx Holdings (GDRX) stake by 0.94% in Q2 2026, selling an estimated $1.38K and leaving 57,302 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #3579.

HighTower Advisors first reported a position in GDRX in Q4 2020 and has held it in 15 quarters since. The position peaked at $2.67M in Q1 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • HighTower Advisors held 57,302 shares of GoodRx Holdings worth $165K as of Q2 2026.
  • HighTower Advisors sold 542 GoodRx Holdings shares in Q2 2026, an estimated $1.38K.
  • GoodRx Holdings made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3579 holding.
  • HighTower Advisors first reported a position in GoodRx Holdings in Q4 2020 and has held it in 15 quarters since.
  • HighTower Advisors's GoodRx Holdings position peaked at $2.67M in Q1 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.